Our Strengths
Invest in Meiji
The combined strengths of our food and pharmaceutical businesses, plus an emphasis on sustainability, help Meiji deliver long-term growth and stakeholder returns.
Products with the highest market shares in Japan
-
- Yogurt
- No.1
- 34.2%
- Market scale 502.8 billion yen
- *1
-
- Chocolate
- No.1
- 26.4%
- Market scale 479.1 billion yen
- *1
-
- Cheese
- No.3
- 9.8%
- Market scale 234.1 billion yen
- *1
-
- Protein
- No.1
- 35.9%
- Market scale 147.9 billion yen
- *2
-
- Systemic antibacterial drugs
- No.1
- 23.8%
- Market scale 201.7 billion yen
- *3
-
- Influenza HA Vaccine
- No.1
- 40.1%
- Market scale 67.2 billion yen
- *3
Source:
- April 2025-March 2026, INTAGE SRI+, Market Share in value, Cumulative Sales
- Based on Meiji data as of March 2026
- Copyright © 2026 IQVIA.
Calculated based on JPM 2026 Mar Mat
Market scope as defined by Meiji Seika Pharma
Reprinted with permission
Food and pharmaceuticals: strength in synergy
Meiji contributes to health and wellness across a number of market categories including food, nutritional products, and pharmaceuticals. Not only does this give us a broad portfolio, we're able to leverage these different strengths into integrated R&D that creates new health value for consumers and society.
Wellness Science Labs
Main areas of business
Food
- Dairy
- Confectionery
- Nurtritions
- Food Solutions
- Other
Pharmaceuticals
- Domestic pharmaceuticals
- Overseas pharamaceuticals
- Vaccines and Veterinary drugs
Net sales ratio by segment (FYE 3/2026)
- Food Business
- 80.2%
- 942.8 billion yen
- Pharmaceutical Business
- 19.8%
- 232.2 billion yen
Net sales ratio by region (FYE 3/2026)
- Japan
- 86.3%
- 1013.8 billion yen
- Overseas
- 13.7%
- 161.3 billion yen
Sustainability: a healthier society
Meiji is committed to fulfilling its environmental and social responsibilities. As professionals in food and health, we're uniquely able to contribute to the health and wellness of individuals, which in turn leads to a healthier society and planet. Our environmental and social policies and performance are regularly updated on our main Sustainability page.
Sustainability 2026 Vision
LEARN MORE
Improved performance and dividends
The Meiji Group has achieved long-term stable growth and shareholder returns through the sales expansion of core businesses.
Net sales
From FYE 3/2022, net sales show the figures after applying revenue recognition accounting standards.
Return on equity (ROE)
EBITDA
Payout ratio
Data Book FY2025-From April 1, 2025 to March 31, 2026-
Data Book FY2025-From April 1, 2025 to March 31, 2026- (Excel 217KB)
